ADC Therapeutics S.A. (NYSE:ADCT) is one of billionaire Steve Cohen’s small-cap stock picks with huge upside potential. On October 16, H.C. Wainwright reaffirmed its Buy rating on ADC Therapeutics (NYSE:ADCT) but lowered the price target from $8 to$7. ADC Therapeutics (ADCT) Secures PIPE Financing, Price Target Adjusted Photo by Michael Longmire on Unsplash The revision follows the company’s announcement of a $60 million PIPE financing deal, which includes the sale of 11.3 million common shares at$4.0 ...